TNO155 |
Katalog-Nr.GC39514 |
TNO155 ist ein potenter selektiver und oral aktiver allosterischer Inhibitor von Wildtyp-SHP2 (IC50=0,011 μ M). TNO155 hat das Potenzial fÜr die Untersuchung von RTK-abhÄngigen malignen Erkrankungen, insbesondere von fortgeschrittenen soliden Tumoren.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1801765-04-7
Sample solution is provided at 25 µL, 10mM.
TNO155 is a potent selective and orally active allosteric inhibitor of wild-type SHP2 (IC50=0.011 µM). TNO155 has the potential for the study of RTK-dependent malignancies, especially advanced solid tumors[1].
[1]. TNO155: SHP2 inhibitor
Average Rating: 5
(Based on Reviews and 24 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *